NCT05969340

Brief Summary

Benign Paroxysmal Positional Vertigo (BPPV) is a benign inner ear disease that causes the patient to experience short episodes of vertigo when there are changes in head position. The current theory on the causes of BPPV is the displacement of the otoconia from the otolith organ to the semicircular canal organs. BPPV's current treatments consist of repositioning maneuvers to readjust the location of the otoconia back to its original place. Even though the treatments are highly successful in many cases, this study, if proven successful, will help confirm this theory and will help diagnose complicated cases where BPPV is recurrent and treatment has been unsuccessful.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Nov 2023

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 14, 2023

Completed
18 days until next milestone

First Posted

Study publicly available on registry

August 1, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

May 1, 2024

Status Verified

April 1, 2024

Enrollment Period

1.3 years

First QC Date

July 14, 2023

Last Update Submit

April 30, 2024

Conditions

Keywords

BPPVOtoconiaultra-high resolution CT-imaging

Outcome Measures

Primary Outcomes (1)

  • Visualisation of presence or absence of otoconia in the posterior semicircular canal by comparing patient with confirmed BPPV symptoms compared to control subjects without BPPV

    The presence or absence of otoconia in the posterior semicircular canal will be assessed qualitatively and semi-quantitatively using the CT parameters for BPPV patients, and the radiological images will be compared to those of control subjects.

    up to 1 hour

Secondary Outcomes (1)

  • Visualization of the presence or absence of otoconia in patients with confirmed Benign Paroxysmal Positional Vertigo (BPPV) symptoms before and after a repositioning procedure.

    up to 1 hour

Study Arms (2)

Experimental group

EXPERIMENTAL

Patient diagnosed with Posterior canal BPPV

Diagnostic Test: ultra-high-resolution CT-scan

Control group

PLACEBO COMPARATOR

Patient who are scheduled for CT-imaging as part of standard clinical routine and do not have BPPV

Diagnostic Test: ultra-high-resolution CT-scan

Interventions

Use of ultra-high-resolution CT-scan to detect otoconia in the posterior canal BPPV

Control groupExperimental group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Experimental Group:
  • Diagnosed with Posterior canal BPPV.
  • Age 18 or older.
  • Clear nystagmus consistent with canal direction and stimulation.
  • Mild or greater complaints (none, mild, moderate, severe).
  • Crescendo decrescendo nystagmus pattern.
  • Slow phase eye velocity ≥ 15 deg/sec.
  • Control Group:
  • Scheduled for CI implantation CT scan.
  • Age 18 or older.

You may not qualify if:

  • Experimental Group:
  • Anterior or lateral canal BPPV.
  • Inability to undergo CRM and DH maneuvers.
  • Central vestibular disorders.
  • Multi-canal BPPV or subjective BPPV.
  • Pregnancy.
  • Control Group:
  • BPPV, central vestibular disorders, multicanal BPPV, subjective BPPV.
  • Ossifying labyrinthitis, DFNA9, obstructive vestibular schwannoma on MRI.
  • Normal VHIT or history of meningitis.
  • Pregnancy or other vestibular pathologies.
  • Past history of BPPV.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (6)

  • von Brevern M, Radtke A, Lezius F, Feldmann M, Ziese T, Lempert T, Neuhauser H. Epidemiology of benign paroxysmal positional vertigo: a population based study. J Neurol Neurosurg Psychiatry. 2007 Jul;78(7):710-5. doi: 10.1136/jnnp.2006.100420. Epub 2006 Nov 29.

    PMID: 17135456BACKGROUND
  • von Brevern M, Bertholon P, Brandt T, Fife T, Imai T, Nuti D, Newman-Toker D. Benign paroxysmal positional vertigo: Diagnostic criteria. J Vestib Res. 2015;25(3-4):105-17. doi: 10.3233/VES-150553.

    PMID: 26756126BACKGROUND
  • Dorigueto RS, Mazzetti KR, Gabilan YP, Gananca FF. Benign paroxysmal positional vertigo recurrence and persistence. Braz J Otorhinolaryngol. 2009 Jul-Aug;75(4):565-72. doi: 10.1016/s1808-8694(15)30497-3.

    PMID: 19784427BACKGROUND
  • Yamane H, Konishi K, Anniko M. Visualization of horizontal canal benign paroxysmal positional vertigo using 3DCT imaging and its assessment. Acta Otolaryngol. 2021 May;141(5):482-489. doi: 10.1080/00016489.2021.1892822. Epub 2021 Mar 29.

    PMID: 33781168BACKGROUND
  • Rajendran K, Voss BA, Zhou W, Tao S, DeLone DR, Lane JI, Weaver JM, Carlson ML, Fletcher JG, McCollough CH, Leng S. Dose Reduction for Sinus and Temporal Bone Imaging Using Photon-Counting Detector CT With an Additional Tin Filter. Invest Radiol. 2020 Feb;55(2):91-100. doi: 10.1097/RLI.0000000000000614.

    PMID: 31770297BACKGROUND
  • Benson JC, Rajendran K, Lane JI, Diehn FE, Weber NM, Thorne JE, Larson NB, Fletcher JG, McCollough CH, Leng S. A New Frontier in Temporal Bone Imaging: Photon-Counting Detector CT Demonstrates Superior Visualization of Critical Anatomic Structures at Reduced Radiation Dose. AJNR Am J Neuroradiol. 2022 Apr;43(4):579-584. doi: 10.3174/ajnr.A7452. Epub 2022 Mar 24.

    PMID: 35332019BACKGROUND
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The radiologist assessing the CT imaging will be blinded to which participants have positive posterior canal BPPV.
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: There are 2 groups involved: * The experimental group * The control group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Audiologist, PhD Candidate

Study Record Dates

First Submitted

July 14, 2023

First Posted

August 1, 2023

Study Start

November 1, 2023

Primary Completion

March 1, 2025

Study Completion

March 1, 2025

Last Updated

May 1, 2024

Record last verified: 2024-04